CA2396719A1 - 22 human secreted proteins - Google Patents

22 human secreted proteins Download PDF

Info

Publication number
CA2396719A1
CA2396719A1 CA002396719A CA2396719A CA2396719A1 CA 2396719 A1 CA2396719 A1 CA 2396719A1 CA 002396719 A CA002396719 A CA 002396719A CA 2396719 A CA2396719 A CA 2396719A CA 2396719 A1 CA2396719 A1 CA 2396719A1
Authority
CA
Canada
Prior art keywords
polypeptide
seq
cells
polynucleotide
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002396719A
Other languages
English (en)
French (fr)
Inventor
Craig A. Rosen
George A. Komatsoulis
Kevin P. Baker
Charles E. Birse
Daniel R. Soppet
Henrik S. Olsen
Paul A. Moore
Ping Wei
Reinhard Ebner
D. Roxanne Duan
Yanggu Shi
Gil H. Choi
Michele Fiscella
Jian Ni
Steven M. Ruben
Steven C. Barash
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences, Inc.
Craig A. Rosen
George A. Komatsoulis
Kevin P. Baker
Charles E. Birse
Daniel R. Soppet
Henrik S. Olsen
Paul A. Moore
Ping Wei
Reinhard Ebner
D. Roxanne Duan
Yanggu Shi
Gil H. Choi
Michele Fiscella
Jian Ni
Steven M. Ruben
Steven C. Barash
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences, Inc., Craig A. Rosen, George A. Komatsoulis, Kevin P. Baker, Charles E. Birse, Daniel R. Soppet, Henrik S. Olsen, Paul A. Moore, Ping Wei, Reinhard Ebner, D. Roxanne Duan, Yanggu Shi, Gil H. Choi, Michele Fiscella, Jian Ni, Steven M. Ruben, Steven C. Barash filed Critical Human Genome Sciences, Inc.
Publication of CA2396719A1 publication Critical patent/CA2396719A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002396719A 2000-01-31 2001-01-17 22 human secreted proteins Abandoned CA2396719A1 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US17906500P 2000-01-31 2000-01-31
US60/179,065 2000-01-31
US18062800P 2000-02-04 2000-02-04
US60/180,628 2000-02-04
US22627900P 2000-08-18 2000-08-18
US60/226,279 2000-08-18
US25198800P 2000-12-05 2000-12-05
US60/251,988 2000-12-05
US25967801P 2001-01-05 2001-01-05
US60/259,678 2001-01-05
PCT/US2001/001434 WO2001054708A1 (en) 2000-01-31 2001-01-17 22 human secreted proteins

Publications (1)

Publication Number Publication Date
CA2396719A1 true CA2396719A1 (en) 2001-08-02

Family

ID=27539005

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002396719A Abandoned CA2396719A1 (en) 2000-01-31 2001-01-17 22 human secreted proteins

Country Status (4)

Country Link
EP (1) EP1251863A4 (de)
AU (1) AU2001237958A1 (de)
CA (1) CA2396719A1 (de)
WO (1) WO2001054708A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030149237A1 (en) * 2000-06-27 2003-08-07 Corine Vernet Novel polynucleotides and polypeptides encoded thereby
US7981420B2 (en) * 2000-12-22 2011-07-19 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. Therapeutic use of antibodies directed against repulsive guidance molecule (RGM)
DE60129848T2 (de) * 2000-12-28 2008-04-24 Shionogi & Co., Ltd. Chordin-ähnliche polypeptide und deren dns
US7125663B2 (en) 2001-06-13 2006-10-24 Millenium Pharmaceuticals, Inc. Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
JP2003245084A (ja) 2001-12-20 2003-09-02 Morinaga Milk Ind Co Ltd 脳梁又は精子の形成不全の診断及び治療に有用な新規遺伝子、並びにその用途
WO2003089608A2 (en) 2002-04-18 2003-10-30 The General Hospital Corporation Drg11-responsive (dragon) gene family
AU2003271579A1 (en) * 2002-09-02 2004-03-19 Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung Proteins involved in the regulation of energy homeostasis
DE10254601A1 (de) * 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
AU2015242979B2 (en) * 2002-11-22 2016-12-01 Ganymed Pharmaceuticals Ag Genetic products differentially expressed in tumors and the use thereof
AU2013260709C1 (en) * 2004-05-18 2016-09-08 Astellas Pharma Inc. Genetic products differentially expressed in tumors and the use thereof
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
ES2547866T3 (es) 2005-02-16 2015-10-09 The General Hospital Corporation Uso de proteínas de fusión de hemojuvelina para regular el metabolismo del hierro mediado por hepcidina
JP2009510002A (ja) 2005-09-30 2009-03-12 アボット ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 反発誘導分子（ｒｇｍ）タンパク質ファミリーのタンパク質の結合ドメイン、及びその機能的断片、及びそれらの使用
EP1790664A1 (de) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoklonale Antikörper gegen Claudin-18 zur Behandlung von Krebs
US8895002B2 (en) 2007-04-09 2014-11-25 The General Hospital Corporation Hemojuvelin fusion proteins and uses thereof
US8962803B2 (en) 2008-02-29 2015-02-24 AbbVie Deutschland GmbH & Co. KG Antibodies against the RGM A protein and uses thereof
MX2012006560A (es) 2009-12-08 2012-10-05 Abbott Gmbh & Co Kg Anticuerpos monoclonales contra la proteina rgm a para utilizarse en el tratamiento de degeneracion de capa de fibra de nervio retinal.
PL2807192T3 (pl) 2012-01-27 2019-02-28 Abbvie Deutschland Kompozycja oraz sposób diagnostyki i leczenia chorób związanych ze zwyrodnieniem neurytów
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
WO2013174404A1 (en) 2012-05-23 2013-11-28 Ganymed Pharmaceuticals Ag Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
JP6499079B2 (ja) 2012-11-13 2019-04-10 バイオエヌテック アーゲーＢｉｏＮＴｅｃｈ ＡＧ クローディンを発現するガン疾患を処置するための剤
WO2014127785A1 (en) 2013-02-20 2014-08-28 Ganymed Pharmaceuticals Ag Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
WO2014146672A1 (en) 2013-03-18 2014-09-25 Ganymed Pharmaceuticals Ag Therapy involving antibodies against claudin 18.2 for treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2339043A1 (en) * 1998-09-01 2000-03-09 Genentech, Inc. Further pro polypeptides and sequences thereof
JP2002524103A (ja) * 1998-09-16 2002-08-06 ザイモジェネティクス，インコーポレイティド 胃ポリペプチドｚｓｉｇ２８

Also Published As

Publication number Publication date
EP1251863A1 (de) 2002-10-30
WO2001054708A1 (en) 2001-08-02
AU2001237958A1 (en) 2001-08-07
EP1251863A4 (de) 2005-03-02

Similar Documents

Publication Publication Date Title
US7196164B2 (en) Secreted protein HHTLF25
US20090042792A1 (en) 18 human secreted proteins
CA2396719A1 (en) 22 human secreted proteins
US20050208565A1 (en) 29 human cancer associated proteins
WO2001051504A1 (en) 71 human secreted proteins
US20030203361A1 (en) 13 human colon and colon cancer associated proteins
US20050032168A1 (en) 17 human secreted proteins
US7091315B1 (en) Protein HDPBQ71
US20060057582A1 (en) 83 human secreted proteins
US20030113840A1 (en) 25 human secreted proteins
US20030083481A1 (en) 25 human prostate and prostate cancer associated proteins
US20050208619A1 (en) 29 human secreted proteins
US20030152933A1 (en) Human secreted proteins
EP1317471A1 (de) 21 menschliche sekretierte proteine
WO2002022638A1 (en) 22 human secreted proteins
WO2002018412A1 (en) 17 human secreted proteins
EP1322659A1 (de) 21 humane sezernierte proteine
WO2002026931A2 (en) 71 human secreted proteins
EP1313761A1 (de) 18 menschliche, ausgeschiedene proteine
EP1325020A1 (de) 21 humane sezernierte proteine
EP1317473A1 (de) 17 humane sekretierte proteine
WO2002016390A1 (en) 21 human secreted proteins
WO2002016387A1 (en) 12 human secreted proteins
EP1317468A1 (de) 23 menschliche sekretierte proteine
WO2002028877A1 (en) 24 human secreted proteins

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued